259 related articles for article (PubMed ID: 27550220)
1. Congenital heart defects and left ventricular non-compaction in males with loss-of-function variants in NONO.
Scott DA; Hernandez-Garcia A; Azamian MS; Jordan VK; Kim BJ; Starkovich M; Zhang J; Wong LJ; Darilek SA; Breman AM; Yang Y; Lupski JR; Jiwani AK; Das B; Lalani SR; Iglesias AD; Rosenfeld JA; Xia F
J Med Genet; 2017 Jan; 54(1):47-53. PubMed ID: 27550220
[TBL] [Abstract][Full Text] [Related]
2. Further delineation of the phenotypic spectrum associated with hemizygous loss-of-function variants in NONO.
Sewani M; Nugent K; Blackburn PR; Tarnowski JM; Hernandez-Garcia A; Amiel J; Whalen S; Keren B; Courtin T; Rosenfeld JA; Yang Y; Patterson MC; Pichurin P; McLean SD; Scott DA
Am J Med Genet A; 2020 Apr; 182(4):652-658. PubMed ID: 31883306
[TBL] [Abstract][Full Text] [Related]
3. Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.
Reinstein E; Tzur S; Cohen R; Bormans C; Behar DM
Eur J Hum Genet; 2016 Nov; 24(11):1635-1638. PubMed ID: 27329731
[TBL] [Abstract][Full Text] [Related]
4. Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome.
Carlston CM; Bleyl SB; Andrews A; Meyers L; Brown S; Bayrak-Toydemir P; Bale JF; Botto LD
Am J Med Genet A; 2019 May; 179(5):792-796. PubMed ID: 30773818
[TBL] [Abstract][Full Text] [Related]
5. Novel hemizygous loss-of-function variant in NONO identified in a South African boy.
Coetzer KC; Moosa S
Am J Med Genet A; 2022 Jan; 188(1):373-376. PubMed ID: 34549882
[TBL] [Abstract][Full Text] [Related]
6. 3'UTR Deletion of
Giuffrida MG; Goldoni M; Genovesi ML; Carpentieri G; Torres B; Deac AD; Cecchetti S; Martinelli A; Vaisfeld A; Flex E; Bernardini L
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292043
[No Abstract] [Full Text] [Related]
7. Genetic and phenotypic spectrum in the NONO-associated syndromic disorder.
Roessler F; Beck AE; Susie B; Tobias B; Begtrup A; Biskup S; Caluseriu O; Delanty N; Fröhlich C; Greally MT; Karnstedt M; Klöckner C; Kurtzberg J; Schubert S; Schulze M; Weidenbach M; Westphal DS; White M; Wolf CM; Zyskind J; Popp B; Strehlow V
Am J Med Genet A; 2023 Feb; 191(2):469-478. PubMed ID: 36426740
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Non-ossifying fibromas with pathologic fractures in a patient with
Writzl K; Mavčič B; Maver A; Hodžić A; Peterlin B
Front Genet; 2023; 14():1167054. PubMed ID: 37533431
[TBL] [Abstract][Full Text] [Related]
9. Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects.
Mircsof D; Langouët M; Rio M; Moutton S; Siquier-Pernet K; Bole-Feysot C; Cagnard N; Nitschke P; Gaspar L; Žnidarič M; Alibeu O; Fritz AK; Wolfer DP; Schröter A; Bosshard G; Rudin M; Koester C; Crestani F; Seebeck P; Boddaert N; Prescott K; ; Hines R; Moss SJ; Fritschy JM; Munnich A; Amiel J; Brown SA; Tyagarajan SK; Colleaux L
Nat Neurosci; 2015 Dec; 18(12):1731-6. PubMed ID: 26571461
[TBL] [Abstract][Full Text] [Related]
10. Truncating de novo mutations in the Krüppel-type zinc-finger gene ZNF148 in patients with corpus callosum defects, developmental delay, short stature, and dysmorphisms.
Stevens SJ; van Essen AJ; van Ravenswaaij CM; Elias AF; Haven JA; Lelieveld SH; Pfundt R; Nillesen WM; Yntema HG; van Roozendaal K; Stegmann AP; Gilissen C; Brunner HG
Genome Med; 2016 Dec; 8(1):131. PubMed ID: 27964749
[TBL] [Abstract][Full Text] [Related]
11. [Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects].
Langouët M; Mircsof D; Rio M; Amiel J; Brown SA; Colleaux L
Med Sci (Paris); 2016; 32(6-7):571-3. PubMed ID: 27406762
[No Abstract] [Full Text] [Related]
12. Deficiency of NONO is associated with impaired cardiac function and fibrosis in mice.
Xu X; Jiang H; Lu Y; Zhang M; Cheng C; Xue F; Zhang M; Zhang C; Ni M; Zhang Y
J Mol Cell Cardiol; 2019 Dec; 137():46-58. PubMed ID: 31634484
[TBL] [Abstract][Full Text] [Related]
13. De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
Tokita MJ; Chen CA; Chitayat D; Macnamara E; Rosenfeld JA; Hanchard N; Lewis AM; Brown CW; Marom R; Shao Y; Novacic D; Wolfe L; Wahl C; Tifft CJ; Toro C; Bernstein JA; Hale CL; Silver J; Hudgins L; Ananth A; Hanson-Kahn A; Shuster S; ; Magoulas PL; Patel VN; Zhu W; Chen SM; Jiang Y; Liu P; Eng CM; Batkovskyte D; di Ronza A; Sardiello M; Lee BH; Schaaf CP; Yang Y; Wang X
Am J Hum Genet; 2018 Jul; 103(1):154-162. PubMed ID: 29961569
[TBL] [Abstract][Full Text] [Related]
14.
Chang Y; Wacker J; Ingles J; Macciocca I; King I; ; Semsarian C; McGaughran J; Weintraub RG; Bagnall RD
J Med Genet; 2024 Jan; 61(2):171-175. PubMed ID: 37657916
[No Abstract] [Full Text] [Related]
15. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
[TBL] [Abstract][Full Text] [Related]
16. Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).
Pham DH; Tan CC; Homan CC; Kolc KL; Corbett MA; McAninch D; Fox AH; Thomas PQ; Kumar R; Gecz J
Hum Mol Genet; 2017 Jun; 26(11):2042-2052. PubMed ID: 28334947
[TBL] [Abstract][Full Text] [Related]
17. A novel NONO variant that causes developmental delay and cardiac phenotypes.
Itai T; Sugie A; Nitta Y; Maki R; Suzuki T; Shinkai Y; Watanabe Y; Nakano Y; Ichikawa K; Okamoto N; Utsuno Y; Koshimizu E; Fujita A; Hamanaka K; Uchiyama Y; Tsuchida N; Miyake N; Misawa K; Mizuguchi T; Miyatake S; Matsumoto N
Sci Rep; 2023 Jan; 13(1):975. PubMed ID: 36653413
[TBL] [Abstract][Full Text] [Related]
18. A novel NONO nonsense variant in a fetus with renal abnormalities.
Rodriguez-Revenga L; Nadal A; Borobio V; Álvarez-Mora MI; Madrigal I; Pauta M; Borrell A
Prenat Diagn; 2024 Jan; 44(1):77-80. PubMed ID: 38110236
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
[TBL] [Abstract][Full Text] [Related]
20. Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.
Kharade SS; Parekh VI; Agarwal SK
Endocrinology; 2018 Feb; 159(2):1199-1212. PubMed ID: 29309627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
